Key result
In a cohort of 17 Cameroonian patients with Duchenne Muscular Dystrophy, deletions in the DMD gene occurred in 45.5% of patients and duplications in 27.3%, with both clustered between exons 45 and 50.
Why the study?
Most studies on Duchenne muscular dystrophy were conducted in Caucasian, Asian, and Arab populations, leaving the features of the disease in Africans poorly understood.
Cross-Sectional (n=17)
No
In Cameroonian patients with DMD, diagnosis is frequently delayed until adolescence, and mutations are clustered between exons 45 and 50.
Answers are grounded in this paper and cite their sources.
Highlights need for earlier DMD screening in Cameroon; leaves open generalizability of exon 45-50 clustering beyond this small series.
BACKGROUND: Most of the previous studies on Duchenne Muscular Dystrophy (DMD) were conducted in Caucasian, Asian, and Arab populations. Therefore, little is known about the features of this disease in Africans. In this study, we aimed to determine the clinical characteristics of DMD, and the common mutations associated with this condition in a group of Cameroonian patients. METHODS: We recruited DMD patients and performed a general physical examination on each of them. Multiplex ligand-dependant probe amplification was carried out to investigate exon deletions and duplications in the DMD gene (OMIM: 300377) of patients and their mothers. RESULTS: A total of 17 male patients from 14 families were recruited, aged 14 ± 5.1 (8-23) years. The mean age at onset of symptoms was 4.6 ± 1.5 years, and the mean age at diagnosis was 12.1 ± 5.2 years. Proximal muscle weakness was noted in all patients and calf hypertrophy in the large majority of them (88.2%; 15/17). Flexion contractures were particularly frequent on the ankle (85.7%; 12/14). Wasting of shoulder girdle and thigh muscles was present in 50% (6/12) and 46.2% (6/13) of patients, respectively. No patient presented with hearing impairment. Deletions in DMD gene (OMIM: 300377) occurred in 45.5% of patients (5/11), while duplications were observed in 27.3% (3/11). Both mutation types were clustered between exons 45 and 50, and the proportion of de novo mutation was estimated at 18.2% (2/11). CONCLUSION: Despite the first symptoms of DMD occurring in infancy, the diagnosis is frequently made later in adolescence, indicating an underestimation of the number of cases of DMD in Cameroon. Future screening of deletions and duplications in patients from Cameroon should focus on the distal part of the gene.
No takes yet. Share an insight, caveat, or question.
Wonkam‐Tingang et al. (2020) conducted a cross-sectional in Duchenne Muscular Dystrophy (n=17). DMD gene mutations was evaluated on Proportion of DMD gene deletions and duplications. In a cohort of 17 Cameroonian patients with Duchenne Muscular Dystrophy, deletions in the DMD gene occurred in 45.5% of patients and duplications in 27.3%, with both clustered between exons 45 and 50.
Synapse has enriched 10 related papers. Consider them for comparative context: